Browse by Research Team

Article

Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.
Sedaghat-Hamedani, F., Haas, J., Zhu, F., Geier, C., Kayvanpour, E., Liss, M., Lai, A., Frese, K., Pribe-Wolferts, R., Amr, A., Li, D.T., Samani, O.S., Carstensen, A., Bordalo, D.M., Müller, M., Fischer, C., Shao, J., Wang, J., Nie, M., Yuan, L., Haßfeld, S., Schwartz, C., Zhou, M., Zhou, Z., Shu, Y., Wang, M., Huang, K., Zeng, Q., Cheng, L., Fehlmann, T., Ehlermann, P., Keller, A., Dieterich, C., Streckfuß-Bömeke, K., Liao, Y., Gotthardt, M., Katus, H.A. and Meder, B.
European Heart Journal 38 (46): 3449-3460. 7 December 2017

199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.
Bertrand, A.T., Boennemann, C.G. and Bonne, G.
Neuromuscular Disorders 24 (5): 453-462. May 2014

Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
Waldmueller, S., Erdmann, J., Binner, P., Gelbrich, G., Pankuweit, S., Geier, C., Timmermann, B., Haremza, J., Perrot, A., Scheer, S., Wachter, R., Schulze-Waltrup, N., Dermintzoglou, A., Schoenberger, J., Zeh, W., Jurmann, B., Brodherr, T., Boergel, J., Farr, M., Milting, H., Blankenfeldt, W., Reinhardt, R., Oezcelik, C., Osterziel, K.J., Loeffler, M., Maisch, B., Regitz-Zagrosek, V., Schunkert, H. and Scheffold, T.
European Journal of Heart Failure 13 (11): 1185-1192. November 2011

Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation.
Knoblauch, H., Geier, C., Adams, S., Budde, B., Rudolph, A., Zacharias, U., Schulz-Menger, J., Spuler, A., Yaou, R.B., Nuernberg, P., Voit, T., Bonne, G. and Spuler, S.
Annals of Neurology 67 (1): 136-140. January 2010

Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload.
Panek, A.N., Posch, M.G., Alenina, N., Ghadge, S.K., Erdmann, B., Popova, E., Perrot, A., Geier, C., Dietz, R., Morano, I., Bader, M. and Oezcelik, C.
PLoS ONE 4 (8): e6743. 25 August 2009

Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
Posch, M.G., Perrot, A., Geier, C., Boldt, L.H., Schmidt, G., Lehmkuhl, H.B., Hetzer, R., Dietz, R., Gutberlet, M., Haverkamp, W. and Oezcelik, C.
Heart Rhythm 6 (4): 480-486. April 2009

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
Geier, C., Gehmlich, K., Ehler, E., Hassfeld, S., Perrot, A., Hayess, K., Cardim, N., Wenzel, K., Erdmann, B., Krackhardt, F., Posch, M.G., Bublak, A., Naegele, H., Scheffold, T., Dietz, R., Chien, K.R., Spuler, S., Fuerst, D.O., Nuernberg, P. and Oezcelik, C.
Human Molecular Genetics 17 (18): 2753-2765. 15 September 2008

A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy.
Posch, M.G., Posch, M.J., Geier, C., Erdmann, B., Mueller, W., Richter, A., Ruppert, V., Pankuweit, S., Maisch, B., Perrot, A., Buttgereit, J., Dietz, R., Haverkamp, W. and Oezcelik, C.
Molecular Genetics and Metabolism 95 (1-2): 74-80. September 2008

Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy.
Posch, M.G., Thiemann, L., Tomasov, P., Veselka, J., Cardim, N., Garcia-Castro, M., Coto, E., Perrot, A., Geier, C., Dietz, R., Haverkamp, W. and Oezcelik, C.
Medical Science Monitor 14 (7): CR372-CR374. 1 July 2008

A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
Fokstuen, S., Lyle, R., Munoz, A., Gehrig, C., Lerch, R., Perrot, A., Osterziel, K.J., Geier, C., Beghetti, M., Mach, F., Sztajzel, J., Sigwart, U., Antonarakis, S.E. and Blouin, J.L.
Human Mutation 29 (6): 879-885. June 2008

Mitochondrial transcription factors TFA, TFB1 and TFB2: A search for DNA variants/haplotypes and the risk of cardiac hypertrophy.
Alonso-Montes, C., Castro, M.G., Reguero, J.R., Perrot, A., Oezcelik, C., Geier, C., Posch, M.G., Moris, C., Alvarez, V., Ruiz-Ortega, M. and Coto, E.
Disease Markers 25 (3): 131-139. 2008

Dysfunction of dysferlin-deficient hearts.
Wenzel, K., Geier, C., Qadri, F., Huebner, N., Schulz, H., Erdmann, B., Gross, V., Bauer, D., Dechend, R., Dietz, R., Osterziel, K.J., Spuler, S. and Oezcelik, C.
Journal of Molecular Medicine 85 (11): 1203-1214. November 2007

Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross, C.M., Perrot, A., Geier, C., Posch, M.G., Hassfeld, S., Kramer, J., Schmidt, S., Derer, W., Dietz, R. and Oezcelik, C.
Journal of Invasive Cardiology 19 (6): 261-264. 1 June 2007

Mutations in the EGF-CFC gene Cryptic are an infrequent cause of congenital heart disease.
Oezcelik, C., Bit-Avragim, N., Panek, A., Gaio, U., Geier, C., Lange, P.E., Dietz, R., Posch, M.G., Perrot, A. and Stiller, B.
Pediatric Cardiology 27 (6): 695-698. December 2006

Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers.
Perrot, A., Sigusch, H.H., Naegele, H., Genschel, J., Lehmkuhl, H., Hetzer, R., Geier, C., Perez, L.V., Reinhard, D., Dietz, R., Osterziel, K.J. and Schmidt, H.H.
European Journal of Heart Failure 8 (5): 484-493. August 2006

Constitutive upregulations of titin-based signalling proteins in KY deficient muscles.
Beatham, J., Gehmlich, K., van der Ven, P.F.M., Sarparanta, J., Williams, D., Underhill, P., Geier, C., Fuerst, D.O., Udd, B. and Blanco, G.
Neuromuscular Disorders 16 (7): 437-445. July 2006

Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
Wenzel, K., Carl, M., Perrot, A., Zabojszcza, J., Assadi, M., Ebeling, M., Geier, C., Robinson, P.N., Kress, W., Osterziel, K.J. and Spuler, S.
Human Mutation 27 : 599-600. June 2006

Familiaere dilatative Kardiomyopathie [Familial dilated cardiomyopathy].
Osterziel, K.J., Hassfeld, S., Geier, C. and Perrot, A.
Herz 30 : 529-534. 1 September 2005

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.
Geier, C., Perrot, A., Ozcelik, C., Binner, P., Counsell, D., Hoffmann, K., Pilz, B., Martiniak, Y., Gehmlich, K., van der Ven, P.F.M., Furst, D.O., Vornwald, A., von Hodenberg, E., Nuernberg, P., Scheffold, T., Dietz, R. and Osterziel, K.J.
Circulation 107 (10): 1390-1395. 18 March 2003

Distribution and transport of cholesterol in Caenorhabditis elegans.
Matyash, V., Geier, C., Henske, A., Mukherjee, S., Hirsh, D., Thiele, C., Grant, B., Maxfield, F.R. and Kurzchalia, T.V.
Molecular Biology of the Cell 12 (6): 1725-1736. June 2001

Review

Back to square one: what do we know about the functions of muscle LIM protein in the heart?
Gehmlich, K., Geier, C., Milting, H., Fuerst, D. and Ehler, E.
Journal of Muscle Research and Cell Motility 29 (6-8): 155-158. December 2008

Der ploetzliche Herztod bei familiaerer hypertropher Kardiomyopathie. Identifizierung von Hochrisikopatienten [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
Pellnitz, C., Geier, C., Perrot, A., Dietz, R., Osterziel, K.J. and Haverkamp, W.
Deutsche Medizinische Wochenschrift 130 : 1150-1154. 1 January 2005

Kardiale Manifestationen bei Muskeldystrophien [Cardiac manifestations of muscular dystrophies].
Perrot, A., Spuler, S., Geier, C., Dietz, R. and Osterziel, K.J.
Zeitschrift fuer Kardiologie 94 : 312-320. 1 January 2005

Letter

Guiding the molecular diagnosis of hypertrophic cardiomyopathy.
Geier, C., Schulze-Bahr, E. and Bonne, G.
Journal of Thoracic and Cardiovascular Surgery 143 (5): 1234. May 2012

Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients.
Posch, M.G., Panek, A., Kersten, A., Ghadge, S.K., Geier, C., Richter, S., Perrot, A., Gailani, M., Dietz, R., Lueftner, D. and Oezcelik, C.
International Journal of Cardiology 145 (1): 105-106. 5 November 2010

"MLP: A Stress Sensor Goes Nuclear" By Sylvia Gunkel, Joerg Heineke, Denise Hilfiker-Kleiner, Ralph Knoell, J Mol Cell Cardiol. 2009;47(4):423-5.
Gehmlich, K., Ehler, E., Perrot, A., Fuerst, D.O. and Geier, C.
Journal of Molecular and Cellular Cardiology 48 (2): 424-425. February 2010

Hypertrophic cardiomyopathy - a matter of genes.
Geier, C., Elgeti, T. and Ozcelik, C.
Canadian Journal of Anaesthesia 55 (5): 309-311. May 2008

Subacute coronary stent thrombosis in cancer patients.
Gross, C.M., Posch, M.G., Geier, C., Olthoff, H., Kraemer, J., Dechend, R., Dietz, R. and Oezcelik, C.
Journal of the American College of Cardiology 51 (12): 1232-1233. 25 March 2008

Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects.
Posch, M.G., Perrot, A., Schmitt, K., Mittelhaus, S., Esenwein, E.M., Stiller, B., Geier, C., Dietz, R., Gessner, R., Oezcelik, C. and Berger, F.
American Journal of Medical Genetics A 146 (2): 251-253. 15 January 2008

Letter by Geier et al regarding article, "Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction".
Geier, C., Perrot, A. and Oezcelik, C.
Circulation 115 (23): e622. 12 June 2007

Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy.
Hassfeld, S., Eichhorn, C., Stehr, K., Naegele, H., Geier, C., Steeg, M., Ranke, M.B., Oezcelik, C. and Osterziel, K.J.
Heart 93 (3): 359-360. 1 March 2007

A new LMNA mutation causing limb girdle muscular dystrophy 1B.
Spuler, S., Geier, C., Osterziel, K.J., Gutberlet, M., Genschel, J., Lehmann, T.N., Zinn-Justin, S., Gilquin, B. and Schmidt, H.
Journal of Neurology 252 (5): 621-623. May 2005